IGF-DES

What is IGF-DES?

IGF-DES (Insulin-like Growth Factor DES(1-3)) is a modified form of IGF-1, a naturally occurring hormone similar in molecular structure to insulin. IGF-1 plays a crucial role in childhood growth and has anabolic effects in adults. The DES(1-3) form is a truncated variant of IGF-1, with the first three amino acids (Gly-Pro-Glu) removed. This modification significantly increases its biological activity by reducing its affinity for IGF-binding proteins (IGFBPs), thereby increasing its availability to interact with IGF-1 receptors on target tissues.

IGF-DES is commonly used in research settings, sports enhancement (though banned by many organizations), and potentially for regenerative medicine purposes, although its use in mainstream clinical practice is not FDA-approved.

Dosage Forms and Strengths

IGF-DES is typically supplied as:

• Lyophilized powder in vials, usually for reconstitution with bacteriostatic water.

• Common strengths include 100 mcg to 1 mg per vial, depending on the manufacturer.

It is important to note that dosing is experimental and should be guided by a healthcare professional or researcher familiar with peptide usage.

Brand and Generic Names

• Generic Name: IGF-1 DES(1-3), IGF-DES

• Common Brand Names (often used in research contexts): None officially FDA-approved, but found under research supplier labels like:

  • Peptide Sciences IGF-DES

  • BioTech IGF-DES

  • SwissChems IGF-DES

Because this peptide is generally sold for "research purposes only," naming and branding can vary, and users should exercise caution regarding supplier reliability.

Indications for Use

Though not officially approved for clinical use, potential applications of IGF-DES include:

• Muscle regeneration and repair: Promotes muscle cell proliferation and differentiation.

• Tissue healing: May accelerate recovery from injuries, especially tendon or ligament damage.

• Anti-aging research: Investigated for potential rejuvenating effects on organs and skin.

• Neuroprotection: Some studies suggest neuroregenerative properties.

Note: These indications are experimental and not approved by regulatory bodies for treatment in humans.

Mechanism of Action

IGF-DES works by binding to the IGF-1 receptor on the surface of cells, activating intracellular signaling pathways such as the PI3K/Akt and MAPK pathways. This activation leads to:

• Cell proliferation

• Protein synthesis

• Muscle hypertrophy

• Inhibition of apoptosis (cell death)

The removal of the first three amino acids allows IGF-DES to have a 10x greater potency than IGF-1 in some tissues due to lower affinity to IGFBPs, which otherwise reduce IGF-1 activity.

Administration and Dosage

Route of Administration:

• Subcutaneous (SubQ) or Intramuscular (IM) injections are the most common.

Dosage:

• Typical research dosages range from 10–50 mcg per injection, once or twice daily.

• It is often injected directly into or near the muscle intended for growth or repair.

Because no official dosing guidelines exist, this must be done under professional supervision in experimental contexts.

Side Effects and Precautions

Potential Side Effects:

• Hypoglycemia (due to insulin-like effects)

• Joint pain

• Water retention

• Enlarged organs (if abused)

• Injection site reactions

Precautions:

• Not for use in individuals with active cancers, as IGF can promote cell growth indiscriminately.

• Should not be used during pregnancy or breastfeeding.

• May interact with insulin or other growth-related hormones.

Use of IGF-DES should be limited to supervised, ethical research settings due to the risk of uncontrolled cell proliferation and unknown long-term effects.

Conclusion

IGF-DES is a potent, bioactive variant of IGF-1 with enhanced tissue-regenerative potential due to its increased receptor activity and lower binding to IGFBPs. Although promising in muscle and tissue repair, its use remains experimental and carries risks that must be carefully managed. As such, IGF-DES is primarily confined to the realms of research and is not currently approved for general medical use. Its potential in regenerative medicine warrants further study, but safety concerns and regulatory limitations should guide its responsible application.

• Model: IGF DES
• Brand: